Anti-eNOS (phospho S1177) antibody [EPR20991]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(43 Publications)
Anti-eNOS (phospho S1177) antibody [EPR20991] (ab215717) is a rabbit monoclonal antibody detecting eNOS in Western Blot, IP, Dot Blot. Suitable for Human, Mouse.
- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications
View Alternative Names
Nitric oxide synthase 3, Constitutive NOS, EC-NOS, NOS type III, cNOS, NOSIII, Endothelial NOS, eNOS, NOS3
- IP
Supplier Data
Immunoprecipitation - Anti-eNOS (phospho S1177) antibody [EPR20991] (AB215717)
eNOS (phospho S1177) was immunoprecipitated from 0.35 mg of HUVEC (human umbilical vein endothelial cell line) treated with 10 ng/ml VEGF for 5 min, whole cell lysate with ab215717 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab215717 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.
Lane 1 : HUVEC treated with VEGF whole cell lysate 10 μg (Input).
Lane 2 : ab215717 IP in HUVEC treated with VEGF whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab215717 in HUVEC treated with VEGF whole cell lysate.
Exposure time : 30 seconds.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
The 60 kDa band may be a cleaved form of eNOS (PMID : 16195740).
All lanes:
Immunoprecipitation - Anti-eNOS (phospho S1177) antibody [EPR20991] (ab215717)
Predicted band size: 133 kDa
Observed band size: 140 kDa
true
- WB
Supplier Data
Western blot - Anti-eNOS (phospho S1177) antibody [EPR20991] (AB215717)
Blocking/Dilution buffer : 5% NFDM/TBST.
The 60 kDa band may be a cleaved form of eNOS (PMID : 16195740).
All lanes:
Western blot - Anti-eNOS (phospho S1177) antibody [EPR20991] (ab215717) at 1/1000 dilution
Lane 1:
HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 10 µg
Lane 2:
HUVEC (human umbilical vein endothelial cell line) treated with 100 uM pervanadate for 10 min, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 133 kDa
Observed band size: 140 kDa
true
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-eNOS (phospho S1177) antibody [EPR20991] (AB215717)
Blocking/Dilution buffer : 5% NFDM/TBST.
The 60 kDa band may be a cleaved form of eNOS (PMID : 16195740).
All lanes:
Western blot - Anti-eNOS (phospho S1177) antibody [EPR20991] (ab215717) at 1/1000 dilution
Lane 1:
Untreated HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 10 µg
Lane 2:
HUVEC (human umbilical vein endothelial cell line) treated with 10 ng/ml VEGF for 5 min, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 133 kDa
Observed band size: 140 kDa
true
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-eNOS (phospho S1177) antibody [EPR20991] (AB215717)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-eNOS (phospho S1177) antibody [EPR20991] (ab215717) at 1/1000 dilution
Lane 1:
bEND.3 (mouse brain endothelioma cell line) whole cell lysate at 10 µg
Lane 2:
bEND.3 (mouse brain endothelioma cell line) treated with alkaline phosphatase for 1 hour, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 133 kDa
Observed band size: 140 kDa
true
Exposure time: 2min
- Dot
Supplier Data
Dot Blot - Anti-eNOS (phospho S1177) antibody [EPR20991] (AB215717)
Dot blot analysis of eNOS (phospho S1177) labeled with ab215717 at 1/1000 dilution.
Lane 1 : eNOS (phospho S1177) peptide.
Lane 2 : eNOS non-phospho peptide.
Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.
Exposure time : 1 minute.
Blocking/Dilution buffer : 5% NFDM/TBST.
Related conjugates and formulations (1)
-
Anti-eNOS (phospho S1177) antibody [EPR20991] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-eNOS (phospho S1177) antibody [EPR20991] (ab215717) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Dot Blot in Human, Mouse samples.
What is the molecular weight of eNOS?
Anti-eNOS (phospho S1177) [EPR20991] (ab215717) specifically detects a band for eNOS (UniProt: P29474) at a molecular weight of 133kDa.
Trusted by the scientific community
Anti-eNOS (phospho S1177) [EPR20991] (ab215717) was first used in a scientific publication in 2018 and has been cited over 20 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR20991] also available for your convenience: ab215717, Carrier free - ab230158
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ENOS contributes significantly to the regulation of vascular tone and blood flow by promoting vasodilation. It does not function alone; instead it forms complexes with other proteins to exert its full effect. eNOS activity influences the process of angiogenesis inflammation modulation and platelet aggregation. Through its ability to produce nitric oxide eNOS acts as a signaling molecule helping maintain vascular homeostasis.
Pathways
ENOS is a critical player in the NO signaling pathway and interacts intricately with the PI3K/Akt pathway. Nitric oxide produced by eNOS has a role in signaling cascades that lead to vascular dilation and reduced blood pressure. The PI3K/Akt pathway regulates eNOS activity via phosphorylation enhancing NO production. Other proteins like caveolin-1 and calmodulin modulate eNOS impacting these pathways' outcomes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (43)
Recent publications for all applications. Explore the full list and refine your search
Journal of diabetes research 2025:9601959 PubMed40933728
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 23:496 PubMed40629337
2025
Applications
Unspecified application
Species
Unspecified reactive species
Kidney & blood pressure research 50:442-459 PubMed40451155
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of vascular research 62:96-108 PubMed39827863
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 22:1003 PubMed39506809
2024
Applications
Unspecified application
Species
Unspecified reactive species
Medicine 103:e40118 PubMed39432648
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cardio-oncology (London, England) 10:65 PubMed39367508
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 28:400 PubMed39171145
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:22485 PubMed38110485
2023
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica Polonica 70:843-853 PubMed38051819
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com